Table 3. Incidence of complications within 30 days after ASA in G+ and G− patients.
Adverse event | Genotype+ (n=30) | Genotype− (n=99) | P value |
---|---|---|---|
Death [%] | 0 [0] | 0 [0] | NA |
Stroke [%] | 0 [0] | 0 [0] | NA |
Ventricular tachycardia/fibrillation [%] | 1 [3] | 4 [4] | 0.99 |
Complete heart block [%] | 2 [7] | 20 [20] | 0.10 |
Permanent pacemaker implantation [%] | 1 [3] | 8 [8] | 0.68 |
Cardiopulmonary resuscitation [%] | 1 [3] | 4 [4] | 0.99 |
Vascular access complication [%] | [0] | 2 [2] | 0.99 |